Rini Sekartini

Jakarta, JK, ID 
Jakarta, JK, ID 

Overview

Rini Sekartini practices practicing medicine in Jakarta, Indonesia.

Her clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), Tetanus, Iron Deficiency Anemia, and Typhoid Fever.

She is actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Jakarta, JK 10430, Indonesia
Other Locations
Semarang, JT, Indonesia
Tangerang, BT, Indonesia
Depok, JI, Indonesia
Makassar, SN, Indonesia
Padang, SB, Indonesia
Jakarta Pusat, JK 10430, Indonesia
NB, Indonesia
Bandung, JB, Indonesia
Salemba, JK 10340, Indonesia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Immunogenicity & Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Bio Farma) Adjuvanted With Alum+CpG 1018 Compared to Registered Covid-19 Vaccine (Covovax - Protein Subunit Vaccine) in Healthy Populations Aged 18 Years and Above in Indonesia (Phase III)
Immunogenicity & Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Bio Farma) Adjuvanted With Alum+CpG 1018 Compared to Registered Covid-19 Vaccine (Covovax - Protein Subunit Vaccine) in Healthy Populations Aged 18 Years and Above in Indonesia (Phase III)
Enrollment Status: Completed
Publish Date: November 29, 2023
Intervention Type: Biological
Study Phase: Phase 3
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Bio Farma) Adjuvanted With Alum+CpG 1018 in Healthy Populations Aged 18 Years and Above in Indonesia
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Bio Farma) Adjuvanted With Alum+CpG 1018 in Healthy Populations Aged 18 Years and Above in Indonesia
Enrollment Status: Completed
Publish Date: April 13, 2023
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
A Phase I, Observer-Blind, Randomized, Controlled Study of the Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Adjuvanted With Alum+CpG 1018) in Healthy Populations Aged 18 Years and Above in Indonesia
A Phase I, Observer-Blind, Randomized, Controlled Study of the Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine (Adjuvanted With Alum+CpG 1018) in Healthy Populations Aged 18 Years and Above in Indonesia
Enrollment Status: Completed
Publish Date: February 27, 2023
Intervention Type: Biological
Study Phase: Phase 1
View 2 Less Clinical Trials

51 Total Publications

Associations Between Dairy Consumption and Nutrient Intake in Southeast Asian Children: Findings from the South East Asian Nutrition Surveys II (SEANUTS II).
Associations Between Dairy Consumption and Nutrient Intake in Southeast Asian Children: Findings from the South East Asian Nutrition Surveys II (SEANUTS II).
Journal: Nutrients
Published: November 04, 2025

Frequently Asked Questions about Rini Sekartini

Is Rini Sekartini a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?

MediFind is an objective health platform that identifies experts based on real-world data. Rini Sekartini is classified as an Experienced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rini Sekartini participate in research or clinical trials?

Yes. Rini Sekartini has published 51 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Rini Sekartini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sekartini's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile